The effects of the anxiogenic /3-carboline FG 7142 (N-methyl-B-carboline-Scarboxylate) on motor activity and dopamine release in nucleus accumbens and striatum were measured in the rat. Changes in extracellular homovanillic acid (HVA) concentration, monitored by computer-controlled linear sweep voltammetry with carbon-paste electrodes, were used as an index of changes in dopamine
release. An intraperitoneal injection of FG 7142 was followed by an inhibition of the nocturnal rise in motor activity and in dopamine release in nucleus accumbens, but not striatum. Two days after the drug injection, dopamine release in nucleus accumbens returned to control level and then increased on days 3-6 after the injection;
there was no delayed change in motor activity or in striatal dopamine release. In parallel experiments using ex vivo changes in the ratio of 3,4-dihydroxyphenylacetic acid (DOPAC) to dopamine as an index of changes in dopamine turnover, a similar early depression and delayed increase of dopamine turnover in nucleus accumbens, with no change in striatum, was found after an intraperitoneal injection of FG 7142. Regression analysis of motor activity versus dopamine release showed a decrease in correlation between these 2 parameters for nucleus accumbens but not striatum after FG 7142 injection. These results suggest that the inverse benzodiazepine receptor agonist FG 7 142 has a biphasic effect on dopamine release from mesolimbic neurons and support the hypothesis that dopamine release in nucleus accumbens and striatum has a modulatory effect on the control of motor activity but does not play a determining role in the regulation of movement.
At present, the functional role of the mammalian striatum and nucleus accumbens, and their involvement in the regulation and initiation of movement, is not clear. Both structures receive major dopaminergic inputs from the midbrain (Ungerstedt, 1971) , and the importance of dopamine in the striatum for motor control is demonstrated by the movement disorders that result from neurotoxic lesions of nigrostriatal dopamine neurons (Makanjuda and Ashcroft, 1982) and by the degeneration of these neurons found in Parkinson's disease in humans (Da Prada et al., 1984) . However, the substantia nigra pars compacta cells show little variation in discharge frequency during changes in motor activity in either the cat (Trulson et al., 198 1) or the rat (Miller et al., 1983) ; this has led to the suggestion that dopamine in the striatum acts as a neuromodulator with a tonic action, rather than as a classical transmitter (McGeer et al., 1984) . The nucleus accumbens has recently been described as an "interface" between the limbic system and the extrapyramidal motor system as it receives inputs from the hippocampus, the amygdala, and thalamic nuclei Cowan, 1973, 1977; Powell and Leman, 1976; Groenwegen et al., 1980; Kelley and Domesick, 1982; Kelley and Stinus, 1984) and projects to the striatum, the globus pallidus, and the substantia nigra (Conrad and Pfaff, 1976; Powell and Leman, 1976; Williams et al., 1977; Nauta et al., 1978) . A dense dopaminergic input to the nucleus accumbens originates in the ventral-tegmental area (VTA) A10 cell group (DahlstrGm and Fuxe, 1965; Ungerstedt, 197 l) , and pharmacological, behavioral and electrophysiological experiments suggest that dopaminergic transmission in the nucleus accumbens plays a role in the initiation of movement and in goal-directed behavior (Mogenson and Yim, 198 1; Neil1 and Justice, 198 1) . Thus, injection of dopamine agonists into the nucleus accumbens produces strong locomotor activation (Jackson et al., 1975; Makanjuda et al., 1980) while (systemic) d-amphetamine-induced locomotor activation, which is thought to be mediated by an increase in dopamine transmission in the nucleus accumbens (Kelly et al., 1975; Pijnenburg et al., 1976; Costa11 et al., 1977) , is antagonized by neuroleptics microinjetted into the nucleus accumbens (Jackson et al., 1975; Pijnenburg et al., 1975) . In contrast, dopamine agonists injected locally into the striatum induce stereotyped behaviors (Costa11 et al., 1979) . The release of dopamine in nucleus accumbens and in striatum seems, therefore, to play different roles in the regulation of motor activity.
Further functional differences between these 2 dopaminergic pathways are demonstrated by their differential responses to stress. The mesolimbic dopaminergic system responds to stress with an increase in dopamine turnover, which is blocked by benzodiazepines (BDZ) (Fadda et al., 1978; Watanabe, 1984) . In contrast, the nigrostriatal dopaminergic system is unaffected by stress (Lavielle et al., 1978) .
Motor Activity, and Dopamine Rel ease FG 7 142 is representative of a class of non-BDZ agents that binds to brain BDZ receptors but lacks the anticonvulsant and anticonflict (anxiolytic) effects of BDZs; instead, it produces opposite effects, which were interpreted as anxiety in both rat (Corda et al., 1983; Petersen and Jensen, 1984; Drugan et al., 1985) and man (Dorow et al., 1983) . Tam and Roth (1985) reported increased mesocortical dopamine turnover after FG 7 142, an effect similar to stress and opposite to BDZs (Fadda et al., 1978; Lavielle et al., 1978) . However, both the BDZ and anxiogenic P-carbolines have similar depressant effects on motor activity in rodents (File et al., 1985; Little, 1986) . It is likely that the effects of BDZs and /?-carbolines on motor activity are mediated by different mechanisms and that, according to current theories of anxiety (Gray, 1978, 198 l) , the depressant effect of the anxiogenic P-carbolines might reflect behavioral inhibition rather than sedation (Little, 1986) .
Because of the technical difficulties of monitoring changes in the release of neurotransmitters in behaving animals, little is known about the relationship between changes in transmitter turnover and associated changes in behavior. Among the techniques designed to detect changes in the chemical composition of brain extracellular fluid in vivo (Marsden, 1984) , computercontrolled linear sweep voltammetry with chronically implanted carbon-paste electrodes is one of the electrochemical methods now available (O 'Neill et al., 1983a, b) . This method is suitable for the continuous monitoring, over a long period of time, of changes in the extracellular concentration of the dopamine metabolite homovanillic acid (HVA) in freely moving rats. Changes in this signal can be used, under certain conditions, as an index of dopamine release (O 'Neill and Fillenz, 1985a, b; Fillenz and O'Neill, 1986) .
The measurement of changes in the ratio of 3,4-dihydroxyphenylacetic acid (DOPAC) to dopamine is another widely used technique for measuring changes in dopamine turnover (Fadda et al., 1978; Lavielle et al., 1978; Dunn and File, 1983) .
We have used ex vivo determination of DOPAC/dopamine (DA) ratios and in viva voltammetry with parallel monitoring of motor activity to study the effect of FG 7 142 on motor activity and on dopamine release in nucleus accumbens and striatum, and have analyzed the relation between the changes in these parameters in an attempt to gain further insight into the role of dopamine release in these 2 brain areas in the control of motor activity.
Materials and Methods
In vivo studies. Carbon-paste working electrodes were prepared and implanted as described previouslv @' Neil1 et al.. 1982) . In brief. carbon paste (2.8 gm carbon pdwder per-l'ml silicone oil) was packed hto 300 pm (o.d.) Teflon-coated silver wire.
Sixteen male Sprague-Dawley rats (270-350 gm) were stereotaxically implanted, under chloral hydrate anesthesia [7 ml/kg, 5% (wt/vol) solution, i.p.1, with these electrodes; silver wires, placed in the cortex, were used for the reference @'Neil1 et al., 1983~) and auxiliary electrodes. The coordinates, with the head level between brenma and lambda, were as follows: nucleus accumbens, AP 1.5 (from bregma), L 1.5 (from breama). DV 7.0 (from skull): striatum. AP -0.5. L 2.7. DV 4.8 (Kijnig aid I&ppel, 19b3) . All r& were i&planted with 2 'working electrodes, either in the left nucleus accumbens and the right striatum or bilaterally in nucleus accumbens or striatum. The position of the electrodes was verified histologically after the experiment.
The animals were given 2-3 d to recover after surgery before being placed in the recording cages and connected to the microcomputercontrolled equipment (O 'Neill et al., 1983b) . Linear sweep voltammograms between 0 and 650 mV were recorded at 12 min intervals at a rate of 5 mV/sec. The background current for each electrode was measured in situ before each experiment, as described previously (O'-Neil1 et al., 1983a) . Following subtraction of the background current, the voltammograms consisted of 3 peaks. Peak 1 was due to the oxidation of ascorbic acid @' Neil1 et al., 1983b) , peak 2 to uric acid (O 'Neill et al., 1984; Mueller et al., 1985) , and the dopamine metabolite HVA was responsible for peak 3 (O 'Neill and Fillenz, 1985a) . The size of this peak was measured as its height above the baseline @'Neil1 and Fillenz, 198 5a) ; changes in the height of this peak were proportional to changes in the concentration of HVA around the electrode tip.
Between the electrochemical recordings (of approximately 9 min duration), the total motor activity of each rat was monitored using a Doppler-shift microwave device linked to the parallel port of the computer interface @'Neil1 and Fillenz, 1985a) . The lighting in the windowless room, also controlled by the computer, was on a 12 hr/12 hr light/dark cvcle. with lights on from 08.00 to 20.00 hours.
-Once connected to thk equipment, the rats were given a further 3 d to get used to the recording cages and to allow the electrodes to equilibrate. Recording started after this settling-down period and continued for 11 d. On day 1 the rats were undisturbed. At the end of the light period of day 2 (20.00 hours), an injection of 0.5 ml vehicle [one drop Tween 80 (DIFCO. West Molesev. UK) in 10 ml distilled water. i.u.l I __ was given. kfter a second undisturbed day (day 3), FG 7 142 (Ferrosan, Copenhagen, Denmark; 10 mg/kg in 0.5 ml vehicle, i.p.) was administered at the end of the light period of day 4 (20.00 hours) and recording continued for a further 7 d (days 5-l 1) without injection.
The nocturnal increase in motor activity was taken as the difference between the mean number of moves for the light and dark periods. The difference between the mean HVA signal for the light and dark periods, expressed as a percentage of the value for the light period, was used to quantify nocturnal changes in HVA levels.
To examine the acute effect of FG 7 142 on the nocturnal increase in motor activity and HVA signals, segments of the recording period were compared. To study the drug effect on motor activity, these segments were chosen as follows: 12.00-20.00 hours for the light segment, 20.00-22.00 hours for the dark segment. Corresponding segments for the HVA data were 18.00-20.00 hours for the light segment and 20.30-21.30 hours for the dark segment. Longer segments for the motor activity recordings were chosen in order to eliminate the considerable fluctuations in movement.
Normalized plots of circadian motor activity were obtained by expressing each value as a percentage of the mean motor activity for the 24 hr recording. The data from the different rats were then averaged for each day and the mean percentage values were reconverted to mean absolute values. Normalized plots of circadian recordings of HVA signals were obtained using the same procedure.
To analyze in more detail the effect of FG 7 142 on the relation between motor activity and the HVA signals, regression analyses between these variables were carried out for a corresponding segment of the recordings (16.00-24.00 hours, 40 points). For this purpose, a weighted moving average of the original data was calculated to reduce the fluctuations inherent in recording small currents (< 1 nA) and to clarify the systematic relationships between the variables. Because changes in extracellular HVA concentration lag behind changes in motor activity, a cross-correlation analysis was performed (O 'Neill and Fillenz, 1985a) ; the highest correlation occurred when the motor activity data were shifted by 40 ? 4 or 48 k 8 min with respect to the HVA data in nucleus accumbens or striatum, respectively.
Student's t test for paired observations was used in all statistical analyses unless otherwise stated. To allow paired comparison with the control data, the data for the 2 control days (days 1 and 3) were averaged for each rat (motor activity) or each electrode (HVA signals). Values of n refer to number of rats (motor activity) and number of electrodes (HVA signals) or, when stated, to number of determinations (rats x days, electrodes x days); p < 0.05 was considered significant. Ex vivo studies. Male Sprague-Dawley rats weighing 200-250 gm were used for all ex vivo experiments.
To assay nocturnal changes in the HVA/DA and DOPACYDA ratios, littermates were killed at either 16.00 or 23.00 hours by pneumothoracic shock followed by decapitation. Brains were quickly removed and placed on ice. The brain areas were dissected out according to the method of Korf (1975, 1976) and homogenized in 2 ml perchloric acid. The homogenate was spun at 1000 x g for 15 min using a MSE super minor centrifuge. The supematant was removed and stored at -20°C.
To study the effect of FG 7142 on DOPAC/DA ratios, littermates I were injected with either 0.5 ml vehicle (one drop Tween 80 in 10 ml distilled water, i.p.) or FG 7142 (10 mg/kg in 0.5 ml vehicle, i.p.) and killed 30 min, 1 hr, 24 hr, or 4 d after the injections. In separate experiments designed to examine whether the acute effect of FG 7 142 was mediated by central BDZ receptors and could be blocked by the imidazodiazepine Ro 15-1788 (flumazepil; Hoffman-LaRoche Co., Basel, Switzerland), a specific BDZ receptor blocker, animals received 2 injections at a time interval of 10 min and were killed 30 min after the second injection. For this purpose animals were treated in 4 groups: the Vehicle Control group-O.5 ml vehicle, i.p., followed after 10 min by 0.5 ml vehicle, i.p.; the FG 7142 group-O.5 ml vehicle, i.p., followed after 10 min by 10 mg/kg FG 7142 in 0.5 ml vehicle, i.p.; the Ro 15-1788 group-20 m&kg Ro 15-1788 in 0.5 ml vehicle, i.p., followed after 10 min by 0.5 ml vehicle, i. group-20 mg/kg Ro 15-1788 in 0.5 ml vehicle, i.p., followed after 10 min by 10 mg/kg FG 7142 in 0.5 ml vehicle, i.p. Brains were removed and areas dissected out and homogenized as described above. Supernatants of the homogenates were stored at -20°C.
All samples were assayed within 24 hr after the experiments by highperformance liquid chromatography (HPLC) with electrochemical detection. The HPLC system consisted of an ACS 300/02 series isocratic pump, a Rheodyne 7 125 sample injection valve with a 50 ~1 injection loop, and a 15 cm Hypersil 3 ODS column with a 5 cm Co-Pel ODS guard column. The electrochemical detection unit consisted of a carbonpaste electrode at a potential of 500 mV and an amperometric controller linked to a chart recorder (Pantos Unicorder U228). The mobile phase consisted of a citrate/acetate buffer containing 0.034 M citric acid, 0.1 M NaOH, 0.185 mM octanesulfonic acid, 0.45% acetic acid, and 10% 
Results
In vivo studies Circadian pattern. The normal motor activity of rats maintained under a 12 hr/ 12 hr light/dark cycle, as well as the HVA signals in nucleus accumbens and striatum, followed a circadian pattern that was characterized by low levels of activity and HVA concentration during the light period and long intervals of high motor activity accompanied by increased HVA levels during the dark periods. The average peak heights for the control period (days 1 and 3) were 0.48 + 0.05 nA (n = 28 determinations) in nucleus accumbens and 0.39 + 0.06 nA (n = 10) in striatum. Acute effect of FG 7142. The injection of FG 7142 (10 mgl kg, i.p.), given at the end of the light period, changed the circadian pattern of motor activity and HVA levels in nucleus accumbens, as shown in Figure 1 . In the drug-injected rats, the abrupt rise in motor activity and HVA levels in nucleus accumbens, which was seen after vehicle injection as well as under control conditions, showed a marked reduction. Figure 1 suggests that the effect of the drug injection was brief and restricted to the early part of the dark period. To study this effect of FG 7 142 in greater detail, a segment of the circadian recordings was examined as described in Materials and Methods. In Figure 2 , segments of the normalized circadian plots of motor activity and HVA levels in nucleus accumbens and striatum are shown following vehicle and drug injection; the data are summarized in Table 1 . Vehicle injection had no effect on the segmental nocturnal increase in motor activity (Fig. 2A) ; there was a 37 f 9% reduction in motor activity following FG 7 142 injection as compared to after vehicle injection (Table 1) . One day after the drug administration, values returned to control levels. Similar results were obtained for the HVA signals in the nucleus accumbens ( Fig. 2B ): Injection of vehicle was without effect; after injection of FG 7 142 the segmental nocturnal rise in HVA levels was reduced by 55 5 19% (Table 1 ) and returned to control levels on the following day. Segmental nocturnal increases in striatal HVA levels did not change after either vehicle or drug administration (Fig. 2C, Table 1 ).
Delayed effect of FG 7142. Nocturnal increases in motor activity and HVA concentration, expressed as a percentage of the mean value over the first 3 d of the experiment, are shown in Figure 3 . The mean decrease over the entire dark period following FG 7 142 administration was 14 _+ 5% for motor activity and 33 f 20% for HVA in nucleus accumbens. The nocturnal increase in HVA levels in the nucleus accumbens returned to control level on day 6; on days 7-10 it rose by 25 + 8% above the mean control value. The histogram in Figure 3B shows the immediate decrease and delayed increase in the nocturnal rise in HVA levels following a single injection of FG 7 142. There were no delayed changes in motor activity (Fig. 3A) . The nocturnal rise in striatal HVA concentrations remained unchanged during the entire course of the experiment (Fig. 3C) .
Correlation analysis between motor activity and HVA levels in nucleus accumbens andstriatum. In order to study the relation between motor activity and HVA levels in nucleus accumbens and striatum in greater detail, regression analyses were carried out for the segment defined above. Correlation coefficients for motor activity versus HVA levels in nucleus accumbens and in striatum over the entire 11 d period are shown in Figure 4 . The correlation coefficients for the striatal data did not change in the course of the experiment; the mean value for the correlation coefficient was 0.80 f 0.02 (n = 46). The correlation coefficient The data for days l-3 (white), day 4 (FG 7 142, cross-hatched) and days 7-l 0 (black) are shown; n values are given in parentheses. *p < 0.05, compared to data for days l-3.
for motor activity versus HVA levels in nucleus accumbens was time shift for maximal correlation in the cross-correlation analunchanged after vehicle injection but was reduced by 33 I~I 7% ysis. This is illustrated for nucleus accumbens in Figure 5 , in after injection of FG 7 142. On subsequent days, correlation which correlation coefficients are plotted against time shift for coefficients returned to control value. There was no change in vehicle-and drug-injected animals. The scatter plots illustrate The segmental nocturnal increase in motor activity was calculated as the difference in the mean number of counts/l2 min scan for a light segment (12.00-20.00 hours) and a dark segment (20.00-22.00 hours; see square bracket in Fig.  24 . The segmental nocturnal increase in HVA levels was calculated as the difference between the average peak heights for a light (18.0-20.00 hours) and a dark segment (20.30-21.30 hours; see square bracket in Fig. 2 Ex vivo studies To obtain a second, independent measure of the effects of FG 7 142 on dopamine turnover, changes in the metabolite-to-transmitter ratio in nucleus accumbens and striatum were measured. Nocturnal changes in metabolite ratios. Both HVA/DA and DOPAC/DA ratios were increased during the dark period in nucleus accumbens and striatum (Table 2) . Nocturnal increases in HVA/DA ratios were 18 * 6% in nucleus accumbens and 14 f 6% in striatum; the increases in DOPAUDA ratios were 21 * 6% in nucleus accumbens and 15 -t 3% in the striatum.
Efect ofFG 7142 on DOPAUDA ratios in nucleus accumbens and striatum. Since HVA/DA and DOPAUDA ratios showed very similar nocturnal rises and DOPAC/DA ratios are more widely used, the latter metabolite ratio was used as the measure of changes in DA turnover. The changes in DOPAC/DA ratios in the nucleus accumbens after a single injection of FG 7142 were found to be biphasic: Animals killed 30 min, 1 hr, or 24 hr after a single injection of FG 7 142 had reduced DOPAUDA ratios, compared to vehicle-injected animals; 4 d after a single injection of FG 7142, DOPACYDA ratios were increased. In vehicle-injected rats DOPAWDA ratios in the nucleus accumbens were significantly greater than in uninjected controls: Increases were 30 f 12% 30 min after the injection, 33 -t 12% 1 hr after the injection, and 51 f 14% (n = 5) 24 hr after the injection. There was no difference in DOPAUDA ratios in the striatum between vehicle-injected and FG 7 142-injected rats (Table 3) or between vehicle-injected and uninjected rats (not shown).
In a separate experiment, the effect of pretreatment of the rats with the specific BDZ receptor blocker Ro 15-1788 (20 mg/kg in 0.5 ml vehicle, i.p.) on the acute effect of FG 7142 on DO-PAC/DA ratios was examined. This pretreatment completely blocked the effect of FG 7 142 (see Table 4 ).
Discussion
In the present study we used 2 distinct but indirect methods to measure changes in dopamine release in nucleus accumbens and striatum following a single intraperitoneal injection of FG 7 142. Evidence that the third peak in voltammograms obtained in nucleus accumbens and striatum using linear sweep voltammetry and carbon-paste electrodes represents extracellular HVA concentration, and that changes in this signal reflect changes in dopamine release, has been presented (O 'Neill and Fillenz, 1985a, b; Fillenz and O'Neill, 1986) . Previous experiments using voltammetry have demonstrated that both motor activity and HVA concentration show very similar circadian changes (O 'Neill and Fillenz, 1985b) . Metabolite-to-transmitter ratios are widely used as a measure for dopamine turnover (Fadda et al., 1978; Lavielle et al., 1978; Dunn and File, 1983) . The similarity in the values for the nocturnal increase of the metabolite/DA ratio, measured ex vivo, and HVA levels, measured in vivo using voltammetry, further validates these techniques and justifies their parallel use. However, changes in metabolite concentration after drug administration must be treated with caution since drugs may produce changes in the metabolite clearance rate (Commissiong, For the day and night value, rats were killed at 16.00 and 23.00 hours, respectively. Brain regions were dissected out, homogenized and centrifuged. DA, DOPAC, and HVA contents in the supematant were measured using HPLC with electrochemical Westerink and Krickert, 1986) . Since, in the present study, FG 7142 had different effects on metabolite levels in nucleus accumbens and striatum, the changes are unlikely to be attributable to an effect on metabolite clearance, as the anatomical proximity ofthe 2 brain areas suggests that their clearance mechanisms have similar characteristics. The reduction in motor activity by a single intraperitoneal injection of FG 7 142 confirms reports of other investigators (File et al., 1985; Little, 1986) and is compatible with the animal model of anxiety, in which behavioral inhibition is a salient feature (Gray, 1978 (Gray, , 1981 . The depression of motor activity had a short duration, comparable to the anxiogenic effect of FG 7142 in man (Dorow et al., 1983) . The effect on dopamine release is seen as a reduction in HVA concentration, measured by voltammetry, in nucleus accumbens but not striatum. Similarly, in drug-injected rats the DOPAUDA ratio was reduced in nucleus accumbens but not striatum, as compared to vehicleinjected animals. This is in sharp contrast with the effects of stress, which result in an increase in dopamine turnover in nucleus accumbens and frontal cortex but not striatum (Fadda et al., 1978; Lavielle et al., 1978; Trulson and Preussler, 1984; Anderson et al., 1985) . Vehicle-injected rats in the present study . l -. .' a*. ., *a. Cross-correlation analysis between the normalized circadian recordings of HVA levels in nucleus accumbens and motor activity for the day of vehicle injection @Ied circles) and the day of the FG 7 142 injection (asterisks) (see Fig. 1 for plots of the circadian recordings), calculated for a segment of the circadian recordings ( 16.OC-24.00 hours, 40 points). Cross-correlation coefficients (r) were calculated by comparing m(t + x) with h,(t) (in the range x = -5 to x = 10; x is the number of scans taken at 12 min intervals), where h,(t) is the height of peak 3 at time t and m(t) is the value ofthe movement counter following that scan. The scatter plots in the insets refer to the optimal cross-correlation: A, vehicle injection; B, FG 7 142 injection. Correlation coefficients are given. Open circles represent points of the preinjection period, filled circles points of the postinjection period.
also showed increased DOPAUDA ratios in nucleus accumbens but not striatum following the stress of an intraperitoneal injection (Anderson et al., 1985) . The failure of the vehicle injection to produce a comparable increase in HVA levels in the in vivo experiments might be due to the fact that, after surgery, animals had developed resistance to such a mild stress. Our studies show an effect of FG 7 142 on dopamine turnover in nucleus accumbens that is similar to the effect of BDZs reported by others (Fadda et al., 1978 ) and no effect on the striatum. However, Tam and Roth (1985) reported that FG 7 142 caused an increase in dopamine turnover in the frontal cortex, an effect opposite to that of BDZs, as well as a decrease in striatum. The decreased nocturnal rise in dopamine turnover in nucleus accumbens returned to control level 2 d after FG 7 142 administration and was followed by a delayed rise. This rise in dopamine turnover was observed with both in vivo and ex vivo methods of measurement. At present, the mechanism of the effect of FG 7 142 on motor activity and dopamine release in nucleus accumbens and striaturn is unclear. FG 7 142, which has pharmacological and behavioral effects opposite to those of BDZs (Biggio, 1983; Corda et al., 1983; Concas et al., 1984; Pellow and File, 1984; Petersen on the acute effect of FG 7 142 (10 mg/kg) on DOPAUDA ratios in nucleus accumbens and striatum. Animals were treated in 4 groups: Vehicle Control group-O.5 ml vehicle, i.p., followed after 10 min by 0.5 ml vehicle, i.p.; FG 7142 group-O.5 ml vehicle, i.p., followed after 10 min by 10 mg/kg FG 7142 in 0.5 ml vehicle. i.o.: Ro 15-1788 arouo-20 me/kg Ro 15-1788 in 0.5 ml vehicle. i.o.. followed after 10 min by 0.5 ml vehicle, i.p.; Rd l>-'1788/FG 7145 gr&p-20mGkg Ro 15-1788 in 0.5 ml veiici 'i.p., followed after 10 min by 10 m&kg FG 7142 in 0.5 ml vehicle, i.p. Animals were killed 30 min after the second injection, brain regions were dissected out, homogenized, and centrifuged. DA and DOPAC contents in the supernatant were measured using HPLC with electrochemical detection. Errors indicate SEMs. "p < 0.05, compared to values from all other groups.
and Jensen, 1984) , when added to membrane preparations of rat cerebral cortex, produces changes in 3H-GABA binding that are opposite to those produced by diazepam . This suggests that whereas BDZs act by enhancing, FG 7 142 acts by depressing GABA transmission. Both VTA A10 and substantia nigra zona compacta dopamine neurons receive inhibitory GABAergic inputs; parallel changes in dopamine release would be expected if a direct action of FG 7 142 on these GABAergic inputs was responsible for the effects that we found. However, there are many possible sites of GABA-mediated action for systemically administered FG 7 142, since the connections of nucleus accumbens include a number of GABAergic steps (Scheel-Kriiger, 1986 ). An action of FG 7142 on several of these could account for both the change in dopamine release and in motor activity. For the long-term effects of FG 7142 there is at present no explanation, but it is interesting to note that Little et al. (1986) described a delayed increase in cortical P-adrenoreceptor density in mice after a single injection of FG 7142. Although the mechanism underlying the FG 7 142 effects is not clear, the drug provides a useful tool for the investigation of the relation between motor activity and dopamine release in the basal ganglia. The parallel decrease in motor activity and dopamine release in nucleus accumbens would suggest that dopamine release in this region is more tightly coupled to motor activity than it is in the striatum. However, a more detailed analysis using linear regression shows that, during the acute drug effect, dopamine release in nucleus accumbens is not as tightly coupled to motor activity as it is in striatum. Thus, motor activity and dopamine release are not always tightly coupled in either nucleus accumbens or striatum. A study on the effect of light reversal led to the same conclusions (Fillenz and O'Neill, 1986) .
Previous studies of the role of dopamine neurons in the basal ganglia in the control of movement have used electrophysiological recordings of single-unit activities in VTA A10 and substantia nigra zona compacta neurons and have found little or no variation in these parameters with movement or during the phases of sleep (Trulson et al., 198 1; Miller et al., 1983; Trulson and Preussler, 1984) . Furthermore, parallel electrophysiological and voltammetric studies in substantia nigra zona compacta and striatum show that changes in dopamine release in striatum can be independent of the firing rate of nigral dopamine neurons (Trulson, 1985) . This suggests that dopamine release in the basal ganglia is not determined solely by impulse frequency, but is also subject to heteroreceptor-mediated presynaptic modulation. The role of presynaptic receptors in the control of dopamine release has been demonstrated in a number of studies with brain slices and synaptosomes (Chesslet, 1984) .
In conclusion, neither single-unit discharge of dopaminergic neurons in VTA A10 or substantia nigra zona compacta nor dopamine release in nucleus accumbens or striatum seems to play a determining role in the control of motor activity.
